Clincosm LogoSign in Get a demo

moderate to severe ulcerative colitis

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Cohort Study Comparing IFX to CS for Moderate to Severe UC

Recruiting
  • Moderate to Severe Ulcerative Colitis
  • Guandong, China
    The Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022

Moderate to Severe Ulcerative Colitis Trial in Worldwide (50 mg Induction/Chronic, 450 mg Induction/Chronic, 150 mg

Completed
  • Moderate to Severe Ulcerative Colitis
  • 50 mg Induction/Chronic
  • +3 more
  • Dothan, Alabama
  • +158 more
Nov 21, 2022

Moderate to Severe Ulcerative Colitis Trial in China (Hemay005 tablets, Hemay005 tablets)

Not yet recruiting
  • Moderate to Severe Ulcerative Colitis
  • Hemay005 tablets
  • Hemay005 placebo tablets
  • Hefei, Anhui, China
  • +17 more
Aug 16, 2022

Moderate to Severe Ulcerative Colitis Trial in Worldwide (CBP-307, Placebo)

Active, not recruiting
  • Moderate to Severe Ulcerative Colitis
  • Phoenix, Arizona
  • +64 more
Apr 20, 2022

Moderate to Severe Ulcerative Colitis Trial (Itacitinib, Placebo)

Withdrawn
  • Moderate to Severe Ulcerative Colitis
  • (no location specified)
Dec 4, 2019

Quality of Life, and Workability in Patients Suffering From

Terminated
Has Results
  • Moderate to Severe Ulcerative Colitis
    • (no location specified)
    Jan 5, 2017